GlomCon

8.9K posts

GlomCon banner
GlomCon

GlomCon

@GlomCon

GlomCon is a resource for the kidney community to exchange ideas, learn, educate, and collaborate on projects. Membership via https://t.co/xPsKBuWGcw

Katılım Mayıs 2016
937 Takip Edilen16.1K Takipçiler
Sabitlenmiş Tweet
GlomCon
GlomCon@GlomCon·
🚨 NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! 🚨 Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence. 🎯 What you'll gain: ✅ Access to premier fellowship programs ✅ Secure database platform for operational and research registry ✅ Exclusive director network meetings ✅ Free conference registration + educational resources ✅ Clinical trial support services ✅ Population health dashboards 🏥 Perfect for: • Academic medical centers • Nephrology Clinics • Healthcare institutions serving rare kidney disease populations 📅 Timeline: Pre-applications open NOW | Framework release Fall 2025 Ready to elevate your rare kidney disease program? Apply today! 👇 ikgplk7aacm.typeform.com/to/CWW3C0VS #RareKidneyDisease #GlomerularDisease #CentersOfExcellence #Nephrology #PatientCare
GlomCon tweet media
English
1
11
31
11.3K
GlomCon
GlomCon@GlomCon·
Starting now 👇 Genetic Determinants of (Idiopathic) Nephrotic Syndrome across Diverse Ancestries, Response to Therapy and Lifespan
GlomCon tweet media
English
0
1
1
197
GlomCon retweetledi
GlomCon Portugal
GlomCon Portugal@GlomConPortugal·
Don't miss our next session on Pregnancy and Glomerular Diseases with Prof. Liz Lightstone 🤰📍
GlomCon Portugal tweet media
English
3
5
12
2.7K
GlomCon retweetledi
Tiffany Caza
Tiffany Caza@Tiff_Caza·
New recommendations for IgAN therapy incorporating BAFF/APRIL blockade and complement inhibitors. By @AKronbichler at @GlomCon
Tiffany Caza tweet media
English
3
17
76
3.6K
GlomCon retweetledi
Tiffany Caza
Tiffany Caza@Tiff_Caza·
Impact of proteinuria reduction on prognosis in IgA nephropathy - justifies use as a surrogate endpoint in clinical trials From @AKronbichler at @GlomCon
Tiffany Caza tweet mediaTiffany Caza tweet media
English
0
18
64
3.4K
GlomCon retweetledi
Izabela Zakrocka
Izabela Zakrocka@IzabelaZakrocka·
Excellent talk by @AKronbichler highlighting the importance of autoimmune diseases control in CKD prevention and treatment, with so many new options ✨@GlomCon
Izabela Zakrocka tweet mediaIzabela Zakrocka tweet mediaIzabela Zakrocka tweet mediaIzabela Zakrocka tweet media
English
1
10
37
1.9K
GlomCon retweetledi
GlomCon Arabia
GlomCon Arabia@glomconarabia·
Don’t miss this timely seminar today! One correction- Lecture will start at 7pm Egypt time (equivalent to 7 pm KSA and Kuwait time, 8 pm UAE time). The rest of the timezones below (besides Egypt) is correct. Thank you for your patience. @GlomCon
GlomCon Arabia@glomconarabia

Join us next Friday May 8 in our next @GlomCon Arabia Seminar as Dr. Abdallah Geara presents a lecture on "Complement Dysregulation in Glomerular Disease." Meeting details below: glomcon.zoom.us Meeting ID: 884 4208 1901 Passcode: 100499 glomcon.org/arabia-glomcon

English
0
3
4
1K
GlomCon retweetledi
Dr. Divya Bajpai 🇮🇳
As nephrologist Iam always interested in looking what it does to kidney tissue? Findings of TMA - 🔬 Great session by Dr Sharon Ford at @GlomCon
Dr. Divya Bajpai 🇮🇳 tweet media
English
0
33
78
3.3K
GlomCon
GlomCon@GlomCon·
The agenda tackles the most contested questions in the field: the IgAN trial designs, lupus multi-targeted regimens, the nephrin revolution in FSGS/MCD, clinical challenges in membranous, and the timing of biopsy and genetic testing and their interpretation. Whether you join in Maui or virtually, we're connecting the global glomerular community. Registration open: glomconhawaii.org #Nephrology #GlomConHawaii
GlomCon tweet mediaGlomCon tweet media
English
0
4
20
860
GlomCon
GlomCon@GlomCon·
Join GlomCon Arabia this coming Friday, May 08 Complement Dysregulation in Glomerular Disease by Dr. Abdallah Geara ID: 884 4208 1901 Passcode: 100499 Visit us 👉🏻 my.glomcon.org #Glomcon #Arabia
GlomCon tweet media
English
0
2
9
475